CALGARY, ALBERTA--(Marketwire - Jan. 25, 2010) - Pan Orient (TSX VENTURE:POE) is pleased to announce an update on operations and the 2010 capital program for Thailand and Indonesia. Highlights include:
-- Thailand Concession L53 (100% WI and operator)
-- L53-D exploration well - oil discovery tested at a restricted rate
of 228 bopd
-- L53-A exploration well - oil discovery tested with combined rate of
337 bopd
-- Thailand Concession L44 (60% WI and operator)
-- Bo Rang "B" Field - BR-2ST2 horizontal appraisal well on production
at 866 bopd
-- High impact NSE-G3 exploration well targeting a new volcanic zone
approaching target depth
-- 2009 average production of 3,369 bopd (net) for the fourth quarter of
2009
-- 2009 exit production of 5,200 bopd (net) excluding test production from
the L53 concession
-- 2010 average production target of 6,000 bopd (net)
-- 2010 capital program of CDN$67 million including 34 development and
exploration wells in Thailand and seven Indonesian high impact
exploration wells
- Forums
- ASX - By Stock
- operations update: disappoint ?
CALGARY, ALBERTA--(Marketwire - Jan. 25, 2010) - Pan Orient (TSX...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVN (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $366.6M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $357.2K | 1.791M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190000 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 832037 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190000 | 0.200 |
5 | 412267 | 0.195 |
19 | 1660975 | 0.190 |
17 | 2285117 | 0.185 |
8 | 821673 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 832037 | 13 |
0.210 | 879729 | 16 |
0.215 | 208847 | 4 |
0.220 | 859761 | 18 |
0.225 | 185001 | 5 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
CVN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online